For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.
Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.
Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
Patients can enter clinical trials before, during, or after starting their cancer treatment.
Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment. You can search for clinical trials at clinicaltrials.gov/.
The National Cervical Cancer Coalition (NCCC), a program of ASHA, is a partner with the University of California, San Francisco on a project to try to understand how best to give women information about their options for screening for cervical cancer. The researchers are looking to speak with women in California who would be willing to participate in focus groups and interviews about their opinions and experiences on this topic. Participants in the focus groups receive $50. Eligible women for this study are:
- between the ages of 21-30 years old
- have had a Pap test
Women in Northern California, specifically the San Francisco Bay area, are especially encouraged to respond. These focus groups are limited in size so if you (or someone you know) is interested or would like more information, please contact us.